Jacks Lee's most recent trade in Vaxcyte Inc was a trade of 15,372 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vaxcyte Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,372 | 15,372 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 3,041 | 4,591 | - | 0 | Common Stock | |
| G1 Therapeutics Inc | Jacks Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 60,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Jacks Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Jacks Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 30,000 | 0 | - | - | Stock Option (right to buy) | |
| G1 Therapeutics Inc | Jacks Lee | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Sep 2024 | 10,000 | 10,000 (0%) | 0% | - | Common Stock | |
| G1 Therapeutics Inc | Jacks Lee | Director | 18 Sep 2024 | 10,000 | 0 (0%) | 0% | - | Common Stock | ||
| G1 Therapeutics Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 10,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| Vaxcyte Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 7,250 | 7,250 | - | - | Stock Option (right to buy) | |
| Vaxcyte Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 1,550 | 1,550 | - | 0 | Common Stock | |
| G1 Therapeutics Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| G1 Therapeutics Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| G1 Therapeutics Inc | Jacks Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2022 | 60,000 | 60,000 | - | - | Stock Options (Right to buy) |